MEK 2 (Ab 394) Antilichaam

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases

5605

P36507

NP_109587.1

Human, Mouse, Rat

MEK-2 (Ab-394) antibody was raised against a peptide sequence around aa.392~396 (P-G-T-P-T) derived from Human MEK-2.

Unconjugated

Primary Antibodies

Other

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

44 kDa

This antibody detects endogenous level of total MEK2 protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

MAP2K2

Mitogen-activated protein kinase kinase 2

Homo sapiens

Crews C M, et al. (1992) Science. 258:478-480. Alessi D R, et al. (1994) EMBO J. 13:1610-1619. Rosen L B, et al. (1994) Neuron. 12:1207-1221. Cowley S, et al. (1994) Cell. 77:841-852.

CFC4, MEK2, MKK2, MAPKK2, PRKMK2, NMDAR1, ERK activator kinase 2, MAP kinase kinase 2, MAP2K2, MAPK/ERK kinase 2, MAPKK 2

WB, IHC

13489054

Liquid